$431 Million is the total value of Altium Capital Management LP's 135 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GLEOWS | Exit | GALILEO ACQUISITION CORP*w exp 10/31/202 | $0 | – | -200,000 | -100.0% | -0.03% | – |
| AMHCW | Exit | AMPLITUDE HLTHCRE AQUSTIN CO*w exp 12/01/202 | $0 | – | -162,500 | -100.0% | -0.04% | – |
| EVAX | Exit | EVAXION BIOTECH A Sads | $0 | – | -24,725 | -100.0% | -0.04% | – |
| GNPX | Exit | GENPREX INC | $0 | – | -60,909 | -100.0% | -0.07% | – |
| CMLFW | Exit | CM LIFE SCIENCES INC*w exp 09/04/202 | $0 | – | -66,666 | -100.0% | -0.10% | – |
| VERB | Exit | VERB TECHNOLOGY CO INC | $0 | – | -281,173 | -100.0% | -0.11% | – |
| CBIO | Exit | CATALYST BIOSCIENCES INC | $0 | – | -89,930 | -100.0% | -0.13% | – |
| VINCW | Exit | VINCERX PHARMA INC*w exp 12/24/202 | $0 | – | -215,250 | -100.0% | -0.24% | – |
| ROCCU | Exit | ROTH CH ACQUISITION II COunit 12/11/2025 | $0 | – | -100,000 | -100.0% | -0.29% | – |
| GIGGU | Exit | GIGCAPITAL4 INCunit 99/99/9999 | $0 | – | -125,000 | -100.0% | -0.34% | – |
| VRAY | Exit | VIEWRAY INC | $0 | – | -289,114 | -100.0% | -0.35% | – |
| BCTG | Exit | BCTG ACQUISITION CORP | $0 | – | -120,000 | -100.0% | -0.37% | – |
| LRMR | Exit | LARIMAR THERAPEUTICS INC | $0 | – | -93,261 | -100.0% | -0.38% | – |
| CMLF | Exit | CM LIFE SCIENCES INC | $0 | – | -100,000 | -100.0% | -0.41% | – |
| XGN | Exit | EXAGEN INC | $0 | – | -86,475 | -100.0% | -0.42% | – |
| BWAY | Exit | BRAINSWAY LTDsponsored ads | $0 | – | -179,506 | -100.0% | -0.45% | – |
| SLRX | Exit | SALARIUS PHARMACEUTICALS INC | $0 | – | -1,250,110 | -100.0% | -0.51% | – |
| LCY | Exit | LANDCADIA HOLDINGS III INC | $0 | – | -192,314 | -100.0% | -0.53% | – |
| MGTA | Exit | MAGENTA THERAPEUTICS INC | $0 | – | -164,381 | -100.0% | -0.54% | – |
| CHRS | Exit | COHERUS BIOSCIENCES INC | $0 | – | -136,623 | -100.0% | -0.55% | – |
| CALA | Exit | CALITHERA BIOSCIENCES INC | $0 | – | -853,902 | -100.0% | -0.57% | – |
| PXS | Exit | PYXIS TANKERS INC | $0 | – | -2,035,793 | -100.0% | -0.58% | – |
| WVE | Exit | WAVE LIFE SCIENCES LTD | $0 | – | -398,997 | -100.0% | -0.62% | – |
| OCUP | Exit | OCUPHIRE PHARMA INC # | $0 | – | -397,036 | -100.0% | -0.64% | – |
| CHFWU | Exit | CONSONANCE HFW ACQUISITION Cunit 99/99/9999 | $0 | – | -250,000 | -100.0% | -0.68% | – |
| TMPMU | Exit | TURMERIC ACQUISITION CORPunit 10/08/2025 | $0 | – | -254,000 | -100.0% | -0.70% | – |
| CFMS | Exit | CONFORMIS INC | $0 | – | -2,608,875 | -100.0% | -0.72% | – |
| GMTX | Exit | GEMINI THERAPEUTICS INC | $0 | – | -203,995 | -100.0% | -0.77% | – |
| NUVA | Exit | NUVASIVE INC | $0 | – | -43,133 | -100.0% | -0.78% | – |
| ITCI | Exit | INTRA CELLULAR THERAPIES INC | $0 | – | -88,326 | -100.0% | -0.83% | – |
| NBEV | Exit | NEWAGE INC | $0 | – | -1,198,150 | -100.0% | -0.95% | – |
| AHACU | Exit | ALPHA HEALTHCARE ACQUISTN COunit 09/21/2027 | $0 | – | -275,000 | -100.0% | -0.95% | – |
| TFFP | Exit | TFF PHARMACEUTICALS INC | $0 | – | -269,691 | -100.0% | -1.02% | – |
| CNST | Exit | CONSTELLATION PHARMCETICLS I | $0 | – | -158,733 | -100.0% | -1.03% | – |
| ARYA | Exit | ARYA SCIENCES ACQUISITION CO | $0 | – | -286,383 | -100.0% | -1.10% | – |
| EUCRU | Exit | EUCRATES BIOMEDICAL ACQU CORunit 10/23/2027 | $0 | – | -400,000 | -100.0% | -1.11% | – |
| HARP | Exit | HARPOON THERAPEUTICS INC | $0 | – | -199,607 | -100.0% | -1.16% | – |
| FBRX | Exit | FORTE BIOSCIENCES INC | $0 | – | -134,542 | -100.0% | -1.28% | – |
| CLSN | Exit | CELSION CORP | $0 | – | -3,496,154 | -100.0% | -1.34% | – |
| MBTCU | Exit | NOCTURNE ACQUISITION CORPunit 02/25/2026 | $0 | – | -500,000 | -100.0% | -1.39% | – |
| STRO | Exit | SUTRO BIOPHARMA INC | $0 | – | -226,719 | -100.0% | -1.43% | – |
| SNDX | Exit | SYNDAX PHARMACEUTICALS INC | $0 | – | -253,448 | -100.0% | -1.57% | – |
| PROG | Exit | PROGENITY INC | $0 | – | -1,748,252 | -100.0% | -2.31% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| FAT BRANDS INC | 12 | Q3 2023 | 0.6% |
| CHINOOK THERAPEUTICS INC | 11 | Q2 2023 | 8.9% |
| BELLUS HEALTH INC NEW | 10 | Q1 2023 | 4.7% |
| XTANT MED HLDGS INC | 10 | Q3 2023 | 5.1% |
| IVERIC BIO INC | 10 | Q1 2023 | 2.3% |
| MYRIAD GENETICS INC | 10 | Q1 2023 | 2.3% |
| HARBOR CUSTOM DEVELOPMENT IN | 10 | Q3 2023 | 0.1% |
| CRINETICS PHARMACEUTICALS IN | 9 | Q3 2023 | 4.1% |
| CTI BIOPHARMA CORP | 9 | Q1 2023 | 2.6% |
| POLISHED COM INC | 9 | Q2 2023 | 3.4% |
View Altium Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Marpai, Inc. | April 26, 2023 | 1,805,327 | 6.2% |
| Astria Therapeutics, Inc. | February 14, 2023 | 1,355,372 | 5.0% |
| HyreCar Inc. | February 14, 2023 | 1,688,120 | 5.6% |
| Muscle Maker, Inc. | February 14, 2023 | 2,888,085 | 5.0% |
| NeuroBo Pharmaceuticals, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| PALISADE BIO, INC.Sold out | February 14, 2023 | 0 | 0.0% |
| 1847 Goedeker Inc. | February 14, 2022 | 6,103,824 | 5.0% |
| BioRestorative Therapies, Inc. | February 14, 2022 | 200,000 | 5.0% |
| BriaCell Therapeutics Corp. | February 14, 2022 | 900,000 | 4.7% |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. | February 14, 2022 | 363,000 | 5.0% |
View Altium Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-02-21 |
| SC 13G | 2024-02-20 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
View Altium Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.